UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000054077
Receipt number R000061751
Scientific Title A prospective observational study of ultra-hypofractionated radiotherapy for postoperative breast cancer patients
Date of disclosure of the study information 2024/04/05
Last modified on 2024/04/05 23:43:50

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A prospective observational study of ultra-hypofractionated radiotherapy for postoperative breast cancer patients

Acronym

A prospective observational study of ultra-hypofractionated radiotherapy for postoperative breast cancer patients

Scientific Title

A prospective observational study of ultra-hypofractionated radiotherapy for postoperative breast cancer patients

Scientific Title:Acronym

A prospective observational study of ultra-hypofractionated radiotherapy for postoperative breast cancer patients

Region

Japan


Condition

Condition

Breast cancer

Classification by specialty

Breast surgery Radiology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To confirm that ultra-short-term irradiation after breast-conserving surgery is safe and effective in Japanese patients.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Adverse events at 1, 3, and 6 months after the start of radiation therapy

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Female

Key inclusion criteria

Patients must be at least 20 years old at the time of consent (no upper age limit).
Patients scheduled for postoperative irradiation as breast-conserving therapy.
Patients who have been thoroughly informed about their participation in this study and have provided written consent of their own free will based on adequate understanding.

Key exclusion criteria

Patients with infections that require systemic treatment.
Pregnant, possibly pregnant, or lactating patients.
Patients who have previously received chest radiation therapy.
Patients are scheduled for concurrent chemotherapy.
Patients with diabetes mellitus who are being treated with continuous insulin injections or are poorly controlled.
Patients diagnosed with interstitial pneumonia, pulmonary fibrosis, or severe emphysema.
Patients receive continuous systemic administration (oral or intravenous) of steroids.
Patients receiving immunosuppressive agents for active collagen disease
Patients with severe cardiac disease or heart failure.
Patients who are deemed ineligible for participation in this study by the principal investigator or principal investigator-designated physicians.

Target sample size

30


Research contact person

Name of lead principal investigator

1st name Noriyuki
Middle name
Last name Okonogi

Organization

Juntendo University

Division name

Department of Radiation Oncology

Zip code

113-8421

Address

2-1-1 Hongo, Bunkyo-ku, Tokyo

TEL

03-5802-1230

Email

n.okonogi.rd@juntendo.ac.jp


Public contact

Name of contact person

1st name Noriyuki
Middle name
Last name Okonogi

Organization

Juntendo University

Division name

Department of Radiation Oncology

Zip code

113-8421

Address

2-1-1 Hongo, Bunkyo-ku, Tokyo

TEL

03-5802-1230

Homepage URL


Email

n.okonogi.rd@juntendo.ac.jp


Sponsor or person

Institute

Juntendo University

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Medical Research Ethics Committee, Juntendo University

Address

Hongo, Bunkyo-ku, Tokyo 1-3

Tel

03-3813-3111

Email

n.okonogi.rd@juntendo.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2024 Year 04 Month 05 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2024 Year 02 Month 19 Day

Date of IRB

2024 Year 03 Month 29 Day

Anticipated trial start date

2024 Year 05 Month 01 Day

Last follow-up date

2025 Year 10 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

After obtaining consent, radiotherapy will be administered according to the regulations, and adverse events will be evaluated at 1, 3, and 6 months after the start of treatment.


Management information

Registered date

2024 Year 04 Month 05 Day

Last modified on

2024 Year 04 Month 05 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000061751


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name